Jeff Geschwind, MD – Cancer Drug Innovator Founder of Cage Pharma, Jeff Geschwind, MD, researches cancer metabolism-targeting drugs, focusing on glycolysis inhibition. His work aims to disrupt tumor growth, providing new hope for aggressive cancer treatments. https://www.onclive.com/authors/jeff-geschwind-md-johns-hopkins